Safety data support human testing of hematopoietic stem cell gene therapy for mucopolysaccharid I – EurekAlert (press release)
|
Safety data support human testing of hematopoietic stem cell gene therapy for mucopolysaccharid I
EurekAlert (press release) New Rochelle, NY, October 6, 2016–Extensive biosafety studies of hematopoietic stem cell (HSC) gene therapy, intended to replace a protein that patients with the inherited disease mucopolysaccaridosis I (MPS I) cannot produce, support clinical testing … |
